BIOMAT Database Logo BIOMAT Database Logo

Using a systems biological approach to develop novel therapeutics. 2002

Christian V Forst
Los Alamos National Laboratory, Los Alamos, NM 87545, USA. chris@lanl.gov

UI MeSH Term Description Entries
D010597 Pharmacogenetics A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION). Pharmacogenomics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Christian V Forst
Using genomics to develop novel antibacterial therapeutics.
November 2010, Critical reviews in microbiology,
Christian V Forst
A biological approach to therapeutics.
January 1953, The Hahnemannian,
Christian V Forst
Targeting O-GlcNAcylation to develop novel therapeutics.
June 2021, Molecular aspects of medicine,
Christian V Forst
Systems approach to therapeutics design.
January 2009, Methods in molecular biology (Clifton, N.J.),
Christian V Forst
Understanding Podocyte Biology to Develop Novel Kidney Therapeutics.
January 2018, Frontiers in endocrinology,
Christian V Forst
Systems biology approach to developing "systems therapeutics".
May 2014, ACS medicinal chemistry letters,
Christian V Forst
Model systems to study plague pathogenesis and develop new therapeutics.
January 2010, Frontiers in microbiology,
Christian V Forst
A novel hybrid approach to develop bioresorbable material.
January 2022, Journal of orthopaedics,
Christian V Forst
Using animal models to develop therapeutics for Tourette Syndrome.
December 2005, Pharmacology & therapeutics,
Christian V Forst
Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy.
February 2024, Arteriosclerosis, thrombosis, and vascular biology,
Copied contents to your clipboard!